1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Wearable Neurorehabilitation Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario
5.3. Reimbursement Scenario
5.4. COVID-19 Pandemic Impact on Industry
6. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2017-2031
6.3.1. Stroke
6.3.2. Spinal Cord Injury
6.3.3. Cerebral Palsy
6.3.4. Others
6.4. Market Attractiveness Analysis, by Application
7. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals/Clinics
7.3.2. Rehabilitation Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Wearable Neurorehabilitation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017-2031
9.2.1. Stroke
9.2.2. Spinal Cord Injury
9.2.3. Cerebral Palsy
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals/Clinics
9.3.2. Rehabilitation Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Wearable Neurorehabilitation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017-2031
10.2.1. Stroke
10.2.2. Spinal Cord Injury
10.2.3. Cerebral Palsy
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals/Clinics
10.3.2. Rehabilitation Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Wearable Neurorehabilitation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017-2031
11.2.1. Stroke
11.2.2. Spinal Cord Injury
11.2.3. Cerebral Palsy
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals/Clinics
11.3.2. Rehabilitation Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Wearable Neurorehabilitation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017-2031
12.2.1. Stroke
12.2.2. Spinal Cord Injury
12.2.3. Cerebral Palsy
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals/Clinics
12.3.2. Rehabilitation Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Wearable Neurorehabilitation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017-2031
13.2.1. Stroke
13.2.2. Spinal Cord Injury
13.2.3. Cerebral Palsy
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals/Clinics
13.3.2. Rehabilitation Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Cadence Biomedical
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Flint Rehab
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Ekso Bionics Holdings, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Myomo, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. ReWalk Robotics
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
